IV Treatment · Glutathione · Skin Lightening

Glutathione IV

How this page was made

This page was written with AI assistance and reviewed against the sources listed under References below. It is general information only, not medical advice. See our full disclaimer for how SHEA creates and reviews treatment information.

What it is

Glutathione is a naturally occurring antioxidant found in cells throughout the body. Intravenous glutathione delivers glutathione directly into the bloodstream through an IV infusion or injection.

Glutathione has also been promoted for skin lightening because of its effects on pathways involved in melanin production. Evidence for skin-lightening effects, however, differs substantially according to how glutathione is administered. Results from oral or topical studies should not automatically be assumed to apply to intravenous treatment.

This page focuses specifically on IV glutathione offered for cosmetic skin-lightening or brightening purposes.

Why people consider it

They are considering IV glutathione because it is marketed for skin lightening or brightening
They want to understand whether intravenous treatment has stronger evidence than oral or topical glutathione
They want to compare the claimed cosmetic benefit with the safety concerns associated with intravenous administration

What the experience is like

Glutathione is administered through a vein. The dose, infusion method, ingredients combined with glutathione, number of treatments, and spacing between treatments can vary between clinics.

There is no well-established cosmetic IV protocol supported by strong clinical evidence. The placebo-controlled study cited below used a preparation containing glutathione together with vitamin C, hydrolyzed collagen, sodium chloride, and water rather than glutathione alone.

Limitations & considerations

Limited evidence and reported serious reactions

Evidence supporting IV glutathione for skin lightening is limited. The placebo-controlled study cited below did not show a statistically significant difference between the treatment and placebo groups, and reported serious adverse events including abnormal liver function tests and one case of anaphylaxis. Clinical reviews have also raised concerns about using intravenous glutathione for cosmetic skin lightening.

The available IV evidence is much more limited than the literature on oral and topical glutathione
A 2025 systematic review identified only one placebo-controlled study of IV glutathione for skin lightening
The IV study used a combination product rather than glutathione alone, so its findings should not be treated as evidence for every IV glutathione formulation
Among participants included in the final comparison, 6 of 16 receiving the IV treatment showed skin-tone improvement compared with 3 of 16 receiving placebo; the difference did not reach conventional statistical significance (p=0.054)
The reported improvement diminished after treatment stopped, with only one participant maintaining the improvement at six months
Abnormal liver function tests and anaphylaxis were reported in the IV study
IV administration also carries risks associated with intravenous treatment and with other ingredients that may be included in a formulation
No particular degree of skin lightening or duration of effect can be guaranteed

Evidence note

The placebo-controlled study of IV glutathione for skin-tone lightening enrolled 50 participants. Thirty-two were included in the final treatment comparison. The treatment preparation contained 1,200 mg glutathione together with vitamin C, hydrolyzed collagen, sodium chloride, and water, and was given twice weekly for six weeks. Among participants included in the final comparison, 6 of 16 in the treatment group showed improvement compared with 3 of 16 in the placebo group. The difference did not reach conventional statistical significance (p=0.054).

The study reported abnormal liver function tests in eight treated participants and anaphylaxis in one participant. Because the treatment contained multiple ingredients, the study cannot establish which component was responsible for either the reported cosmetic changes or adverse reactions.

A 2025 systematic review identified this as the only placebo-controlled IV study meeting its review criteria and concluded that the evidence did not establish sufficient efficacy for IV glutathione as a skin-lightening treatment while also raising safety concerns. Evidence from oral or topical glutathione should not automatically be transferred to intravenous treatment.

References

Peer-reviewed literature.

1. Zubair S, Hafeez S, Mujtaba G. Efficacy of intravenous glutathione vs. placebo for skin tone lightening. Journal of Pakistan Association of Dermatologists, 2016;26(3):177–181.

Peer-reviewed · Placebo-controlled study · IV combination formulation

2. Sarkar R, Yadav V, Yadav T, P J, Mandal I. Glutathione as a skin-lightening agent and in melasma: a systematic review. International Journal of Dermatology, 2025;64(6):992–1004.

Peer-reviewed · Systematic review · IV, oral and topical evidence · No funding or COI reported

3. Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: facts, myths, evidence and controversies. Indian Journal of Dermatology, Venereology and Leprology, 2016;82(3):262–272.

Peer-reviewed · Critical review

4. Davids LM, van Wyk JC, Khumalo NP. Intravenous glutathione for skin lightening: inadequate safety data. South African Medical Journal, 2016;106(8):782–786.

Peer-reviewed · Safety review · IV glutathione